Potential strategies for the eradication of multidrug-resistant Gram-negative bacterial infections

Rawan Huwaitat1, Alice P McCloskey1, Brendan F Gilmore1

  • 1Biofunctional Nanomaterials Group, School of Pharmacy, Queens University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, UK.

Future Microbiology
|July 1, 2016
PubMed

Insights

Multidrug-resistant Gram-negative infections pose a major threat. This review explores novel strategies, including nanotechnology and outer membrane targeting, to combat these resistant bacteria when current therapies fail.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Nanotechnology

Background:

  • Antimicrobial resistance (AMR) is a significant global health threat.
  • Multidrug-resistant Gram-negative bacteria are increasingly prevalent, exhibiting resistance to most available antibiotics.
  • Existing treatments are becoming ineffective against these challenging infections.

Purpose of the Study:

  • To review promising strategies for combating multidrug-resistant Gram-negative infections.
  • To identify potential therapeutic approaches to overcome antibiotic resistance in Gram-negative pathogens.
  • To highlight novel methods for extending antibiotic efficacy.

Main Methods:

  • Literature review of current research on antimicrobial resistance in Gram-negative bacteria.
  • Analysis of emerging therapeutic strategies targeting bacterial mechanisms.
  • Evaluation of nanotechnology-based approaches for antimicrobial applications.

Main Results:

  • Several strategies show promise, including targeting the Gram-negative outer membrane.
  • Neutralization of lipopolysaccharide and inhibition of bacterial efflux pumps are key targets.
  • Silver nanoparticles, liposomes, and nanotubes offer potential for enhancing antibiotic activity.

Conclusions:

  • Novel strategies are crucial to address the threat of multidrug-resistant Gram-negative infections.
  • Repurposing existing antibiotics with new delivery systems or targets is a viable short-term solution.
  • Continued research into innovative treatments is essential to combat the growing AMR crisis.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
37
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.2K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
7
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.9K
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
8